VisionHealth secures €3 million to treat lung disease using its novel AI-powered device
based in Germany Health Vision has confirmed raising €3 million in pre-series A funds to commercialize its AI-based digital app to teach correct ways to use inhalers, to treat lung diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). The round was led by DB specialty investmentwhose owner Dr Dietrich Bruchmann is joining the …